Capital Partners L. P. Tyndall serves as Executive at Onconova Therapeutics, Inc., where they oversee executive responsibilities. Since joining the company, Capital Partners L. P. Tyndall has executed 15 insider transactions totaling $5.8M, demonstrating a bullish approach to their equity position. Their most recent transaction on Sep 24, 2019 involved selling 16,700 shares valued at $19.9K.
Capital Partners L. P. Tyndall currently holds 616,389 shares of Onconova Therapeutics, Inc. (ONTX), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Capital Partners L. P. Tyndall has been a net buyer of ONTX stock. They have purchased $5.5M and sold $352.6K worth of shares.
Capital Partners L. P. Tyndall's most recent insider trade was on Sep 24, 2019, when they sold 16,700 shares at $1.19 per share.
Get notified when new Form 4 filings are submitted
| $1.23 |
| Discretionary |
| Sep 20, 2019 | ONTX | $121.7K | Sale | 75,119 | $1.62 | Discretionary |
| Sep 18, 2019 | ONTX | $105.0K | Sale | 49,995 | $2.10 | Discretionary |
| Sep 11, 2019 | ONTX | $3.4K | Sale | 1,247 | $2.75 | Discretionary |
| Sep 9, 2019 | ONTX | $1.1K | Sale | 400 | $2.77 | Discretionary |
| Sep 6, 2019 | ONTX | $13.9K | Sale | 5,015 | $2.78 | Discretionary |
| Sep 5, 2019 | ONTX | $1.1K | Sale | 400 | $2.75 | Discretionary |
| Jul 10, 2019 | ONTX | $7.7K | Sale | 2,742 | $2.81 | Discretionary |
| Jul 9, 2019 | ONTX | $23.2K | Sale | 8,185 | $2.84 | Discretionary |
| Jun 27, 2019 | ONTX | $5.0K | Sale | 1,458 | $3.45 | Discretionary |
| Jun 25, 2019 | ONTX | $4.7K | Sale | 1,380 | $3.40 | Discretionary |
| Apr 27, 2018 | ONTX | $4.4M | Purchase | 10,147,058 | $0.43 | Discretionary |
| Feb 8, 2018 | ONTX | $1.1M | Purchase | 1,100,000 | $1.01 | Discretionary |
| Apr 21, 2017 | ONTX | $1000.0K | Award | 476,190 | $2.10 | Discretionary |